Beauty brand No7 has announced the launch of its groundbreaking new No7 Future Renew collection, marking the biggest cosmetic science innovation in the beauty brand’s history.

The range consists of four skincare products which have been proven to reverse the appearance of multiple signs of skin damage.

The collection showcases No7’s new ‘super peptide’ formula which harnesses the skin’s natural repair process and the renewal of over 50 important proteins in skin cells. The patent-pending formula also contains two brand new chemical ingredients. 

The No7 Future Renew range has been met with excitement from the global scientific and cosmetics community, with the technology making appearances at leading dermatology conferences across the world.

No7’s new peptide blend is the culmination of 15 years of intense research into skin ageing and repair from No7 and the University of Manchester. The research process included scientific methods and approaches rarely seen in cosmetic product development. The development process involved research within cutting-edge areas of scientific study including advanced robotics, mathematical modelling, bioinformatics, machine learning and cell biology.

In addition to the time consuming development process, No7 also conducted the most extensive and diverse testing programme in the beauty brand’s history. 37 studies were conducted on over 4,200 people, including two clinical trials. More than half of the participants were people of colour.

Unlike other ingredients commonly found in cosmetic products such as retinoic acid, the No7 Future Renew super peptide is suitable for sensitive skin and was found to be highly tolerated by users in the studies. 

Included in the collection is the No7 Future Renew Damage Reversal Serum, which is clinically proven to reverse the appearance of multiple signs of skin damage across a range of different skin types and tones. The serum is targeted to reverse ageing caused by fine lines, wrinkles, lack of luminosity, dryness, uneven skin tone and loss of firmness. In a clinical study, 97% of women reported improvements in the appearance of at least three visible signs of skin damage.  

Additionally, the collection also features the No7 Future Renew Damage Reversal SPF 40 Day Cream which is proven to protect again UV and reverse visible signs of skin damage. The cream contains a formula of SPF 40, No7’s new super peptide blend, antioxidants, niacinamide, hyaluronic acid, Vitamin C and rice proteins to intensely moisturise.

The Future Renew range also includes the  Damage Reversal Night Cream and Eye Serum which are targeted to reverse visible signs of skin damage and to leave the user with intensely nourished and smoother skin. The No7 Future Renew Eye Serum is formulated to reduce puffiness and improve the appearance of wrinkles and uneven skin tones in the delicate area around the eye.  

In response to the launch of Future Renew, Dr Mike Bell, No7’s Head of Scientific Research, says: “The new peptide blend effectively tricks the skin into thinking that it has been damaged which leads to renewal of key proteins such as collagen and fibrillin. It therefore supports the skin’s natural self-repair mechanisms, targeting signs of cumulative damage both on and under the surface. This is a world-first technology only available from No7. We believe it is going to be a game changer for consumers”.  

The No7 Future Renew collection is available nationwide now at Boots stores, Boots.com and no7beauty.co.uk, RRP from £24.95.